Differences Put Aside As ICH Finalizes Guide On Post Approval Changes
Final Q12 Document Adopted At Singapore Meeting
An international guideline on managing post approval changes to drugs, which was initially criticized because of its incompatibility with legal frameworks in certain ICH regions such as the EU, has been finalized.
